Apcotex Industries Limited

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ASIANPAINT.NS has a market cap of 2.5T. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ASIANPAINT.NS trades at ₹2,614.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ASIANPAINT.NS's P/E ratio is 65.14. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ASIANPAINT.NS's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to ASIANPAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ASIANPAINT.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ASIANPAINT.BO has a market cap of 2.5T. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ASIANPAINT.BO trades at ₹2,612.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ASIANPAINT.BO's P/E ratio is 64.96. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ASIANPAINT.BO's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to ASIANPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ASIANPAINT.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SOLARINDS.BO has a market cap of 1.6T. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SOLARINDS.BO trades at ₹18,023.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SOLARINDS.BO's P/E ratio is 97.08. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SOLARINDS.BO's ROE of +0.32%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to SOLARINDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SOLARINDS.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SOLARINDS.NS has a market cap of 1.6T. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SOLARINDS.NS trades at ₹18,019.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SOLARINDS.NS's P/E ratio is 97.26. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SOLARINDS.NS's ROE of +0.32%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to SOLARINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SOLARINDS.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PIDILITIND.NS has a market cap of 1.5T. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PIDILITIND.NS trades at ₹1,450.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PIDILITIND.NS's P/E ratio is 60.25. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PIDILITIND.NS's ROE of +0.24%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to PIDILITIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PIDILITIND.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PIDILITIND.BO has a market cap of 1.5T. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PIDILITIND.BO trades at ₹1,449.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PIDILITIND.BO's P/E ratio is 64.48. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PIDILITIND.BO's ROE of +0.24%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to PIDILITIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PIDILITIND.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SRF.NS has a market cap of 782.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SRF.NS trades at ₹2,639.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SRF.NS's P/E ratio is 42.68. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SRF.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to SRF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SRF.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SRF.BO has a market cap of 782.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SRF.BO trades at ₹2,639.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SRF.BO's P/E ratio is 42.68. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SRF.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to SRF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SRF.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, LINDEINDIA.BO has a market cap of 617.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while LINDEINDIA.BO trades at ₹7,236.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas LINDEINDIA.BO's P/E ratio is 104.93. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to LINDEINDIA.BO's ROE of +0.16%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to LINDEINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check LINDEINDIA.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, LINDEINDIA.NS has a market cap of 615.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while LINDEINDIA.NS trades at ₹7,221.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas LINDEINDIA.NS's P/E ratio is 104.49. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to LINDEINDIA.NS's ROE of +0.16%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to LINDEINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check LINDEINDIA.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, BERGEPAINT.NS has a market cap of 611.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while BERGEPAINT.NS trades at ₹524.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas BERGEPAINT.NS's P/E ratio is 54.31. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to BERGEPAINT.NS's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to BERGEPAINT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check BERGEPAINT.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, BERGEPAINT.BO has a market cap of 611.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while BERGEPAINT.BO trades at ₹524.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas BERGEPAINT.BO's P/E ratio is 56.56. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to BERGEPAINT.BO's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to BERGEPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check BERGEPAINT.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, FLUOROCHEM.NS has a market cap of 405.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while FLUOROCHEM.NS trades at ₹3,694.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas FLUOROCHEM.NS's P/E ratio is 61.79. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to FLUOROCHEM.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to FLUOROCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check FLUOROCHEM.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, FLUOROCHEM.BO has a market cap of 405.2B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while FLUOROCHEM.BO trades at ₹3,688.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas FLUOROCHEM.BO's P/E ratio is 61.69. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to FLUOROCHEM.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to FLUOROCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check FLUOROCHEM.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, HSCL.BO has a market cap of 278.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while HSCL.BO trades at ₹551.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas HSCL.BO's P/E ratio is 36.72. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to HSCL.BO's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to HSCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check HSCL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, HSCL.NS has a market cap of 278.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while HSCL.NS trades at ₹551.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas HSCL.NS's P/E ratio is 36.72. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to HSCL.NS's ROE of +0.18%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to HSCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check HSCL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ACUTAAS.NS has a market cap of 229.2B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ACUTAAS.NS trades at ₹2,799.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ACUTAAS.NS's P/E ratio is 80.07. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ACUTAAS.NS's ROE of +0.24%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ACUTAAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ACUTAAS.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ACUTAAS.BO has a market cap of 229B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ACUTAAS.BO trades at ₹2,797.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ACUTAAS.BO's P/E ratio is 80.04. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ACUTAAS.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ACUTAAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ACUTAAS.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ATUL.NS has a market cap of 202.6B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ATUL.NS trades at ₹6,882.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ATUL.NS's P/E ratio is 29.92. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ATUL.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ATUL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ATUL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ATUL.BO has a market cap of 202.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ATUL.BO trades at ₹6,876.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ATUL.BO's P/E ratio is 34.07. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ATUL.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ATUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ATUL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, KANSAINER.NS has a market cap of 176.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while KANSAINER.NS trades at ₹217.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas KANSAINER.NS's P/E ratio is 29.91. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to KANSAINER.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to KANSAINER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check KANSAINER.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, KANSAINER.BO has a market cap of 176B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while KANSAINER.BO trades at ₹217.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas KANSAINER.BO's P/E ratio is 30.07. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to KANSAINER.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to KANSAINER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check KANSAINER.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, DCMSHRIRAM.BO has a market cap of 171.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while DCMSHRIRAM.BO trades at ₹1,099.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas DCMSHRIRAM.BO's P/E ratio is 20.08. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to DCMSHRIRAM.BO's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to DCMSHRIRAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check DCMSHRIRAM.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, DCMSHRIRAM.NS has a market cap of 171.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while DCMSHRIRAM.NS trades at ₹1,099.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas DCMSHRIRAM.NS's P/E ratio is 20.07. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to DCMSHRIRAM.NS's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to DCMSHRIRAM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check DCMSHRIRAM.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AARTIIND.BO has a market cap of 167.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AARTIIND.BO trades at ₹461.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AARTIIND.BO's P/E ratio is 44.36. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AARTIIND.BO's ROE of +0.07%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to AARTIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AARTIIND.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AARTIIND.NS has a market cap of 167.2B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AARTIIND.NS trades at ₹461.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AARTIIND.NS's P/E ratio is 39.90. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AARTIIND.NS's ROE of +0.07%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to AARTIIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AARTIIND.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, BASF.BO has a market cap of 165.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while BASF.BO trades at ₹3,831.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas BASF.BO's P/E ratio is 44.16. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to BASF.BO's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to BASF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check BASF.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, BASF.NS has a market cap of 165.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while BASF.NS trades at ₹3,831.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas BASF.NS's P/E ratio is 43.78. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to BASF.NS's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to BASF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check BASF.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ANURAS.BO has a market cap of 155.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ANURAS.BO trades at ₹1,362.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ANURAS.BO's P/E ratio is 88.34. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ANURAS.BO's ROE of +0.06%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to ANURAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ANURAS.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ANURAS.NS has a market cap of 155B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ANURAS.NS trades at ₹1,361.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ANURAS.NS's P/E ratio is 88.33. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ANURAS.NS's ROE of +0.06%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to ANURAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ANURAS.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AETHER.BO has a market cap of 148.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AETHER.BO trades at ₹1,116.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AETHER.BO's P/E ratio is 68.78. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AETHER.BO's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to AETHER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AETHER.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AETHER.NS has a market cap of 147.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AETHER.NS trades at ₹1,114.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AETHER.NS's P/E ratio is 68.69. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AETHER.NS's ROE of +0.10%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to AETHER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AETHER.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, VINATIORGA.NS has a market cap of 144B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while VINATIORGA.NS trades at ₹1,388.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas VINATIORGA.NS's P/E ratio is 32.40. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to VINATIORGA.NS's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to VINATIORGA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check VINATIORGA.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, VINATIORGA.BO has a market cap of 143.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while VINATIORGA.BO trades at ₹1,379.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas VINATIORGA.BO's P/E ratio is 32.19. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to VINATIORGA.BO's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to VINATIORGA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check VINATIORGA.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, FINEORG.NS has a market cap of 138.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while FINEORG.NS trades at ₹4,531.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas FINEORG.NS's P/E ratio is 35.07. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to FINEORG.NS's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to FINEORG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check FINEORG.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, FINEORG.BO has a market cap of 138.6B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while FINEORG.BO trades at ₹4,520.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas FINEORG.BO's P/E ratio is 34.89. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to FINEORG.BO's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to FINEORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check FINEORG.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AKZOINDIA.NS has a market cap of 136B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AKZOINDIA.NS trades at ₹2,986.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AKZOINDIA.NS's P/E ratio is 6.95. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AKZOINDIA.NS's ROE of +1.07%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to AKZOINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AKZOINDIA.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AKZOINDIA.BO has a market cap of 136B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AKZOINDIA.BO trades at ₹2,985.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AKZOINDIA.BO's P/E ratio is 6.95. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AKZOINDIA.BO's ROE of +1.07%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to AKZOINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AKZOINDIA.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GRWRHITECH.BO has a market cap of 125.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GRWRHITECH.BO trades at ₹5,384.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GRWRHITECH.BO's P/E ratio is 37.04. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GRWRHITECH.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to GRWRHITECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GRWRHITECH.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GRWRHITECH.NS has a market cap of 125.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GRWRHITECH.NS trades at ₹5,382.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GRWRHITECH.NS's P/E ratio is 37.03. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GRWRHITECH.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to GRWRHITECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GRWRHITECH.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PRIVISCL.NS has a market cap of 120.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PRIVISCL.NS trades at ₹3,095.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PRIVISCL.NS's P/E ratio is 36.94. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PRIVISCL.NS's ROE of +0.27%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to PRIVISCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PRIVISCL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PRIVISCL.BO has a market cap of 120.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PRIVISCL.BO trades at ₹3,095.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PRIVISCL.BO's P/E ratio is 36.94. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PRIVISCL.BO's ROE of +0.27%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to PRIVISCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PRIVISCL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JUBLINGREA.NS has a market cap of 113.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JUBLINGREA.NS trades at ₹721.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JUBLINGREA.NS's P/E ratio is 43.05. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JUBLINGREA.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to JUBLINGREA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JUBLINGREA.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JUBLINGREA.BO has a market cap of 113.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JUBLINGREA.BO trades at ₹720.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JUBLINGREA.BO's P/E ratio is 43.02. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JUBLINGREA.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to JUBLINGREA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JUBLINGREA.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PCBL.NS has a market cap of 105.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PCBL.NS trades at ₹267.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PCBL.NS's P/E ratio is 39.63. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PCBL.NS's ROE of +0.05%. Regarding short-term risk, APCOTEXIND.BO and PCBL.NS have similar daily volatility (3.35).Check PCBL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PCBL.BO has a market cap of 105.2B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PCBL.BO trades at ₹267.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PCBL.BO's P/E ratio is 39.59. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PCBL.BO's ROE of +0.05%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to PCBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PCBL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AMIORG.NS has a market cap of 96.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AMIORG.NS trades at ₹1,176.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AMIORG.NS's P/E ratio is 119.06. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AMIORG.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to AMIORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AMIORG.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, AMIORG.BO has a market cap of 96.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while AMIORG.BO trades at ₹1,176.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas AMIORG.BO's P/E ratio is 118.95. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to AMIORG.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to AMIORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check AMIORG.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ALKYLAMINE.NS has a market cap of 87.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ALKYLAMINE.NS trades at ₹1,711.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ALKYLAMINE.NS's P/E ratio is 48.69. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ALKYLAMINE.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ALKYLAMINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ALKYLAMINE.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ALKYLAMINE.BO has a market cap of 87.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ALKYLAMINE.BO trades at ₹1,710.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ALKYLAMINE.BO's P/E ratio is 48.56. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ALKYLAMINE.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ALKYLAMINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ALKYLAMINE.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, CLEAN.BO has a market cap of 79.6B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while CLEAN.BO trades at ₹749.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas CLEAN.BO's P/E ratio is 32.43. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to CLEAN.BO's ROE of +0.16%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to CLEAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check CLEAN.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, CLEAN.NS has a market cap of 79.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while CLEAN.NS trades at ₹747.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas CLEAN.NS's P/E ratio is 32.40. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to CLEAN.NS's ROE of +0.16%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to CLEAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check CLEAN.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, KINGFA.NS has a market cap of 71.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while KINGFA.NS trades at ₹5,303.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas KINGFA.NS's P/E ratio is 41.48. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to KINGFA.NS's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to KINGFA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check KINGFA.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, KINGFA.BO has a market cap of 71.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while KINGFA.BO trades at ₹5,266.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas KINGFA.BO's P/E ratio is 41.30. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to KINGFA.BO's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to KINGFA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check KINGFA.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SUDARSCHEM.NS has a market cap of 67.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SUDARSCHEM.NS trades at ₹856.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SUDARSCHEM.NS's P/E ratio is -108.47. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SUDARSCHEM.NS's ROE of -0.02%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to SUDARSCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SUDARSCHEM.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SUDARSCHEM.BO has a market cap of 67.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SUDARSCHEM.BO trades at ₹856.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SUDARSCHEM.BO's P/E ratio is 126.73. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SUDARSCHEM.BO's ROE of -0.02%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to SUDARSCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SUDARSCHEM.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GALAXYSURF.BO has a market cap of 64.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GALAXYSURF.BO trades at ₹1,825.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GALAXYSURF.BO's P/E ratio is 23.04. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GALAXYSURF.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to GALAXYSURF.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GALAXYSURF.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GALAXYSURF.NS has a market cap of 64.6B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GALAXYSURF.NS trades at ₹1,822.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GALAXYSURF.NS's P/E ratio is 23.01. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GALAXYSURF.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to GALAXYSURF.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GALAXYSURF.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, BALAMINES.BO has a market cap of 57.2B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while BALAMINES.BO trades at ₹1,764.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas BALAMINES.BO's P/E ratio is 39.75. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to BALAMINES.BO's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to BALAMINES.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check BALAMINES.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, BALAMINES.NS has a market cap of 57.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while BALAMINES.NS trades at ₹1,763.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas BALAMINES.NS's P/E ratio is 39.59. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to BALAMINES.NS's ROE of +0.09%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to BALAMINES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check BALAMINES.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, POCL.BO has a market cap of 47B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while POCL.BO trades at ₹1,539.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas POCL.BO's P/E ratio is 41.21. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to POCL.BO's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to POCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check POCL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, POCL.NS has a market cap of 46.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while POCL.NS trades at ₹1,537.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas POCL.NS's P/E ratio is 41.13. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to POCL.NS's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to POCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check POCL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, RESPONIND.BO has a market cap of 46.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while RESPONIND.BO trades at ₹172.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas RESPONIND.BO's P/E ratio is 25.61. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to RESPONIND.BO's ROE of +0.13%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to RESPONIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check RESPONIND.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, RESPONIND.NS has a market cap of 46.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while RESPONIND.NS trades at ₹172.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas RESPONIND.NS's P/E ratio is 25.57. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to RESPONIND.NS's ROE of +0.13%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to RESPONIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check RESPONIND.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, INDIGOPNTS.NS has a market cap of 45.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while INDIGOPNTS.NS trades at ₹962.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas INDIGOPNTS.NS's P/E ratio is 31.92. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to INDIGOPNTS.NS's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to INDIGOPNTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check INDIGOPNTS.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, INDIGOPNTS.BO has a market cap of 45.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while INDIGOPNTS.BO trades at ₹961.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas INDIGOPNTS.BO's P/E ratio is 31.85. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to INDIGOPNTS.BO's ROE of +0.14%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to INDIGOPNTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check INDIGOPNTS.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GULFOILLUB.BO has a market cap of 44.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GULFOILLUB.BO trades at ₹906.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GULFOILLUB.BO's P/E ratio is 12.91. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GULFOILLUB.BO's ROE of +0.23%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to GULFOILLUB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GULFOILLUB.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GULFOILLUB.NS has a market cap of 44.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GULFOILLUB.NS trades at ₹905.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GULFOILLUB.NS's P/E ratio is 12.90. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GULFOILLUB.NS's ROE of +0.23%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to GULFOILLUB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GULFOILLUB.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, NEOGEN.BO has a market cap of 44.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while NEOGEN.BO trades at ₹1,694.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas NEOGEN.BO's P/E ratio is 226.17. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to NEOGEN.BO's ROE of +0.03%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to NEOGEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check NEOGEN.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, NEOGEN.NS has a market cap of 44.6B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while NEOGEN.NS trades at ₹1,691.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas NEOGEN.NS's P/E ratio is 225.78. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to NEOGEN.NS's ROE of +0.03%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to NEOGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check NEOGEN.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, LXCHEM.NS has a market cap of 41.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while LXCHEM.NS trades at ₹151.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas LXCHEM.NS's P/E ratio is 52.64. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to LXCHEM.NS's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to LXCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check LXCHEM.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, LXCHEM.BO has a market cap of 41.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while LXCHEM.BO trades at ₹151.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas LXCHEM.BO's P/E ratio is 52.63. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to LXCHEM.BO's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to LXCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check LXCHEM.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, TANFACIND.BO has a market cap of 41.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while TANFACIND.BO trades at ₹2,098.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas TANFACIND.BO's P/E ratio is 59.74. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to TANFACIND.BO's ROE of +0.22%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to TANFACIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check TANFACIND.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ADVENZYMES.NS has a market cap of 40.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ADVENZYMES.NS trades at ₹363.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ADVENZYMES.NS's P/E ratio is 26.75. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ADVENZYMES.NS's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ADVENZYMES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ADVENZYMES.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ADVENZYMES.BO has a market cap of 40.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ADVENZYMES.BO trades at ₹363.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ADVENZYMES.BO's P/E ratio is 26.77. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ADVENZYMES.BO's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ADVENZYMES.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ADVENZYMES.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, VISHNU.NS has a market cap of 39B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while VISHNU.NS trades at ₹579.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas VISHNU.NS's P/E ratio is 28.24. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to VISHNU.NS's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to VISHNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check VISHNU.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, VISHNU.BO has a market cap of 38.9B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while VISHNU.BO trades at ₹578.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas VISHNU.BO's P/E ratio is 28.13. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to VISHNU.BO's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to VISHNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check VISHNU.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JINDALPOLY.NS has a market cap of 30.2B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JINDALPOLY.NS trades at ₹689.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JINDALPOLY.NS's P/E ratio is -14.20. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JINDALPOLY.NS's ROE of -0.06%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to JINDALPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JINDALPOLY.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JINDALPOLY.BO has a market cap of 30.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JINDALPOLY.BO trades at ₹687.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JINDALPOLY.BO's P/E ratio is -23.21. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JINDALPOLY.BO's ROE of -0.06%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to JINDALPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JINDALPOLY.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, TATVA.BO has a market cap of 29.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while TATVA.BO trades at ₹1,253.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas TATVA.BO's P/E ratio is 89.30. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to TATVA.BO's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to TATVA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check TATVA.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, TATVA.NS has a market cap of 29.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while TATVA.NS trades at ₹1,252.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas TATVA.NS's P/E ratio is 89.78. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to TATVA.NS's ROE of +0.04%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to TATVA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check TATVA.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GRAUWEIL.BO has a market cap of 28.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GRAUWEIL.BO trades at ₹63.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GRAUWEIL.BO's P/E ratio is 20.50. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GRAUWEIL.BO's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to GRAUWEIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GRAUWEIL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, GRAUWEIL.NS has a market cap of 28.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while GRAUWEIL.NS trades at ₹63.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas GRAUWEIL.NS's P/E ratio is 20.48. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to GRAUWEIL.NS's ROE of +0.15%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to GRAUWEIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check GRAUWEIL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PREMEXPLN.BO has a market cap of 28.5B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PREMEXPLN.BO trades at ₹529.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PREMEXPLN.BO's P/E ratio is 66.07. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PREMEXPLN.BO's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to PREMEXPLN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PREMEXPLN.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, PREMEXPLN.NS has a market cap of 28.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while PREMEXPLN.NS trades at ₹528.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas PREMEXPLN.NS's P/E ratio is 65.93. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to PREMEXPLN.NS's ROE of +0.17%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to PREMEXPLN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check PREMEXPLN.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SOTL.NS has a market cap of 28B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SOTL.NS trades at ₹409.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SOTL.NS's P/E ratio is 15.42. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SOTL.NS's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to SOTL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SOTL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, SOTL.BO has a market cap of 28B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while SOTL.BO trades at ₹407.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas SOTL.BO's P/E ratio is 15.38. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to SOTL.BO's ROE of +0.11%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to SOTL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check SOTL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ROSSARI.BO has a market cap of 27.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ROSSARI.BO trades at ₹500.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ROSSARI.BO's P/E ratio is 18.58. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ROSSARI.BO's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to ROSSARI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ROSSARI.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, ROSSARI.NS has a market cap of 27.7B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while ROSSARI.NS trades at ₹500.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas ROSSARI.NS's P/E ratio is 18.57. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to ROSSARI.NS's ROE of +0.12%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to ROSSARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check ROSSARI.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, POLYPLEX.NS has a market cap of 27.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while POLYPLEX.NS trades at ₹871.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas POLYPLEX.NS's P/E ratio is 90.59. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to POLYPLEX.NS's ROE of +0.01%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to POLYPLEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check POLYPLEX.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, POLYPLEX.BO has a market cap of 27.3B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while POLYPLEX.BO trades at ₹870.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas POLYPLEX.BO's P/E ratio is 90.44. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to POLYPLEX.BO's ROE of +0.01%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to POLYPLEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check POLYPLEX.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, NOCIL.BO has a market cap of 27B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while NOCIL.BO trades at ₹161.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas NOCIL.BO's P/E ratio is 42.92. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to NOCIL.BO's ROE of +0.03%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to NOCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check NOCIL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, NOCIL.NS has a market cap of 27B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while NOCIL.NS trades at ₹161.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas NOCIL.NS's P/E ratio is 48.69. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to NOCIL.NS's ROE of +0.03%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to NOCIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check NOCIL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JUBLCPL.NS has a market cap of 26B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JUBLCPL.NS trades at ₹1,714.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JUBLCPL.NS's P/E ratio is 21.44. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JUBLCPL.NS's ROE of +0.33%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to JUBLCPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JUBLCPL.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JUBLCPL.BO has a market cap of 25.8B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JUBLCPL.BO trades at ₹1,701.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JUBLCPL.BO's P/E ratio is 21.29. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JUBLCPL.BO's ROE of +0.13%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to JUBLCPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JUBLCPL.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JUBLINDS.NS has a market cap of 25.6B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JUBLINDS.NS trades at ₹1,633.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JUBLINDS.NS's P/E ratio is 72.49. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JUBLINDS.NS's ROE of +0.13%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to JUBLINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JUBLINDS.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, JUBLINDS.BO has a market cap of 25.4B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while JUBLINDS.BO trades at ₹1,623.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas JUBLINDS.BO's P/E ratio is 72.31. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to JUBLINDS.BO's ROE of +0.13%. Regarding short-term risk, APCOTEXIND.BO is less volatile compared to JUBLINDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check JUBLINDS.BO's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, TIDEWATER.NS has a market cap of 25.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while TIDEWATER.NS trades at ₹1,479.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas TIDEWATER.NS's P/E ratio is 16.90. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to TIDEWATER.NS's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to TIDEWATER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check TIDEWATER.NS's competition here

APCOTEXIND.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, APCOTEXIND.BO stands at 24.9B. In comparison, TIDEWATER.BO has a market cap of 25.1B. Regarding current trading prices, APCOTEXIND.BO is priced at ₹481.20, while TIDEWATER.BO trades at ₹1,478.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

APCOTEXIND.BO currently has a P/E ratio of 29.91, whereas TIDEWATER.BO's P/E ratio is 16.90. In terms of profitability, APCOTEXIND.BO's ROE is +0.18%, compared to TIDEWATER.BO's ROE of +0.20%. Regarding short-term risk, APCOTEXIND.BO is more volatile compared to TIDEWATER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APCOTEXIND.BO.Check TIDEWATER.BO's competition here